UKAD Statement following WADA advice on COVID-19 vaccines

Following the World Anti-Doping Agency’s (WADA) publication of their position on COVID-19 vaccines, UK Anti-Doping (UKAD) have released the following statement.

UKAD’s Head of Science and Medicine, Nick Wojek said, “We welcome the statement made by WADA regarding their position on COVID-19 vaccines. UK athletes should feel confident that they will not be in breach of the World Anti-Doping Code if they receive the Pfizer-BioNTech vaccine.

“The health and wellbeing of athletes is of primary importance to us and we understand the deployment of new vaccines will raise questions from athletes. We will continue to liaise with WADA so that athletes continue to receive the assurances they need about the anti-doping status of new vaccines as they are approved for use.”

Athletes are encouraged to read the WADA guidance here.

Since the outset of the COVID-19 crisis UKAD has been issuing guidance on the steps taken to protect athletes and staff, while keeping sport clean. You can review all of this guidance on our information pages here.

Updated 11 January 2021

Global DRO will continue to be updated as COVID-19 vaccines are approved for clinical use within the UK, thus we encourage athletes and their support personnel to check Global DRO for updates on the anti-doping status of vaccines going forwards.

The three vaccines currently listed on Global DRO are:

  • Pfizer-BioNTech vaccine (searchable as ‘COVID-19 mRNA Vaccine BNT162b2’)
  • Oxford-AstraZeneca vaccine (searchable as ‘COVID-19 Vaccine AstraZeneca’)
  • Moderna vaccine (searchable as ‘COVID-19 Vaccine Moderna’)